Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, experts say that things are looking up for regenerative medicine.
Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, experts say that things are looking up for regenerative medicine.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
Sign up for the Funding Newswire
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
